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Abstract
Livers and hearts from mice deficient in glycerol-3-phosphate acyltransferase 1 (GPAT1; Gpat12/2) have a decreased
content of glycerolipid intermediates and triacylglycerol, an altered composition of liver phospholipids, and elevated
markers of oxidative stress. Compared with control C57BL/6 mice, infection of Gpat12/2 mice with coxsackievirus B3
(CVB3) resulted in higher mortality, an ;50% increase in heart pathology, a significant increase in liver viral titers, and a
100-fold increase in heart viral titers. Moreover, heart mRNA levels for proinflammatory cytokines tumor necrosis factor-a,
interleukin (IL)-6, and IL-1B were increased in the Gpat12/2 mice. Loss of Gpat1 also resulted in dysregulation of specific
immune cells. Splenic dendritic cells from Gpat12/2 mice were fully capable of stimulating T cells from control mice;
however, splenic T cells from Gpat12/2 mice were defective in their response to CVB3 antigen. Our data indicate that a
lack of GPAT1 activity affects both innate and adaptive immune mechanisms. Innate mechanisms may be affected by
altered membrane composition or host redox status, whereas the adaptive response may require GPAT1 activity
itself. J. Nutr. 139: 779–783, 2009.
Introduction
Effective control and viral clearance during infection requires a
number of highly synchronized immune cells that can each, in
turn, be affected by individual metabolic processes such as
glycolysis and lipogenesis. Glycerol-3-phosphate acyltransferase
1 (GPAT1)4 is located on the mitochondrial outer membrane and
catalyzes the first and rate-limiting step in the synthesis of
glycerophospholipids and triacylglycerol (TAG). GPAT1 is 1 of 4
GPAT isoforms that initiate de novo membrane glycerophos-
pholipid biosynthesis and it esterifies primarily SFA at the sn-1
position of glycerol-3-phosphate (1–3). In most tissues, GPAT1
comprises ;10% of the total GPAT activity; however, in liver, it
comprises ;30–50% of total GPAT activity. GPAT1 may play a
critical role in disorders such as obesity, diabetes, and athero-
sclerosis, because the expression of GPAT1 mRNA has been
shown to be nutritionally and hormonally regulated when TAG
synthesis is increased (4,5).
Although it is clear that GPAT1 plays a pivotal role in TAG
synthesis, recent evidence suggests an important role for the en-
zyme in immune function. GPAT1 influences biological membrane
composition (2), which can have a profound effect on immune cell
interactions and signaling pathways. Absence of GPAT1 results in
decreases in the second messengers diacylglycerol and lysophos-
phatidic acid and increases in the amount of arachidonate in
membrane phospholipids in the liver and heart (6–9). In addition, a
decrease of GPAT1 activity in aging T-lymphocytes may contribute
to age-dependent immune depression. Compared with T-cells from
young controls, T cells isolated from aged mice show decreased
GPAT1activityandproliferative capacitywhenstimulatedwithmi-
togen. T cells isolated from GPAT1 knockout mice (Gpat12/2) un-
dergo similar changes (10–12).
Although GPAT1 activity has the potential to affect immune
status of the host in vitro, the importance of GPAT1 activity for
the immune response and the subsequent control and clearance
of a viral infection has not yet been elucidated. We hypothesized
that the absence of GPAT1 activity might alter the immune
response to a viral challenge. To study the effect of GPAT1
during infection, we used coxsackievirus B3 (CVB3), a major
cause of viral myocarditis in humans. Acute CVB3 myocarditis
is a principal cause of heart failure in young adults and can
progress to chronic myocarditis, dilated cardiomyopathy, and
congestive heart failure (13–15). Viral infectivity, viral persis-
tence, and host immune response may all contribute to the
severity of CVB3 pathogenesis (16). Mice with CVB3-induced
myocarditis have been used a model for the human disease for
over 50 y (17). After the initial infection in the intestinal tract by
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intraperitoneal injection, the virus infects the liver and pancreas
by d 2 or 3 postinfection (p.i.) and can be detected in the heart
between d 4 and 5 p.i. Acute myocarditis usually occurs at d 7–
14 p.i (18,19). The pathogenesis of the virus in the mouse is
identical to the progression observed in the human disease.
To determine the effect of a lack of GPAT1 activity on both
the immune response and on viral replication kinetics, we
infected Gpat12/2 and wild-type C57BL/6 mice with CVB3 and
measured the pathological outcome, the amount of viral rep-
lication, and the host immune response. We found that a
deficiency in GPAT1 clearly altered the ability of the host to
respond effectively to CVB3 infection.
Materials and Methods
Gpat12/2 mice and CVB3 infection. Gpat12/2 mice were generated
previously in the Coleman laboratory on a C57BL/6 background (1) and
knockout and wild-type mice were bred in-house. Male C57BL/6J and
Gpat12/2 mice were housed in the University of North Carolina Animal
Facility, which is fully accredited by the American Association for
Accreditation of Laboratory Animal Care. Mice were maintained under
protocols approved by the Institutional Animal Use and Care Commit-
tee. All mice were housed under a 12–h-light/-dark schedule with free
access to food and water. Male C57BL/6J and Gpat12/2 mice at 2 to
3 mo of age were inoculated intraperitoneally with 105 median tissue
culture infective dose (TCID50) CVB3/59 in 0.1-mL sterile minimum
essential media. CVB3/59 has been shown to produce myocardial
pathology in BL/6 mice (19,20).
Pathology. Mice were killed at d 10 p.i. by cervical dislocation and their
hearts were removed and transversely cut in half. One half of each heart
was embedded in Optimal Cutting Temperature Compound (Tissue-Tek)
and frozen on dry ice. Frozen sections (6 mm) were stained with
hematoxylin and eosin. The extent of heart pathology was graded in a
semiquantitative manner according to the relative degree (from heart to
heart) of mononuclear cell infiltrate and the extent of necrosis.
Quantitation of viral titers. HeLa cells were plated in 96-well flat-
bottom plates. Tissue samples were weighed, ground in minimum
essential media, frozen and thawed 5 times, and centrifuged at 9300 3 g;
10 min at 4C. The supernate was collected and filtered. Serial 10-fold
dilutions of supernate were added in replicates of 6 to the HeLa cell
plates. Following 2–3 d of incubation, viral cytopathic effect was scored
for each well and TCID50 was determined by the method of Reed and
Muench (21).
Quantitation of heart mRNA cytokine levels. Heart samples were
collected on d 5 p.i. and total RNAwas isolated using the TRIzol method
(Invitrogen). RT was carried out with a Superscript II First Strand
Synthesis kit (Invitrogen) using oligo (dT) primers. Following previously
described methods (22), mRNA levels for murine interferon (IFN) a,
IFNb, IFNg, interleukin (IL)-1b, IL-6, IL-10, tumor necrosis factor-a
(TNFa), inducible nitric oxide synthase (iNOS), and glyceraldehyde-3-
phosphate dehydrogenase (G3PDH) were determined using quantitative
real-time PCR.
Determination of natural killer cell cytotoxicity. Following previ-
ously published methods (22), isolated Gpat12/2 and wild-type spleen
cells were analyzed in a natural killer (NK) cell cytotoxicity assay (23)
using 51Cr-labeled YAC-1 tumor cells (American Type Culture Collec-
tion) as targets.
Antigen presentation by dendritic cells. Following previously
published methods (24), spleens from uninfected Gpat12/2 and wild-
type mice were collected and dendritic cells (DC) were isolated using a DC
enrichment kit (Dynal). T cells were isolated from the spleens of wild-type
C57BL/6 mice that had been infected with CVB3/59 10 d before. DC were
incubated at a multiplicity of infection of 10 with UV-inactivated CVB3/
59 for 2 h followed by extensive washing to remove excess virus. Serial
dilutions of 0.1 mL DC starting at 1 3 106 cells/mL were plated with
1 3 105 T cells in a 96-well plate, resulting in DC:Tratios of 1:1, 1:2, and
1:4. All samples were prepared in triplicate and incubated for 2 h at 37C
followed by the addition of Golgi Plug (BD Biosciences) and incubation
for an additional 4 h. Cells were then stained with fluorescein isothio-
cyanate-anti-CD3, allophycocyanin-anti-CD4, andperidinin-chlorophyll-
protein complex anti-CD8 (BD Biosciences) followed by fixation and
permeabilization for subsequent intracellular staining with PE-anti-IFNg.
PE-goat-anti-IgG (Sigma) was used as a staining control. Cells were then
analyzed on a flow cytometer (FACSCalibur).
T cell response to presented antigen. DC were isolated from
uninfected wild-type mice and incubated with UV-inactivated virus as
described above. Splenic T cells from Gpat12/2 and wild-type mice
infected 10 d before were isolated as above. Wild-type DC and T cell
groups were incubated together and analyzed as above.
Subcellular fractionation and GPAT enzyme assays. Livers from
wild-type and Gpat12/2 were collected at d 0 (uninfected), 2, 5, and 10
p.i. Livers were homogenized with 10 up-and-down strokes in a Teflon-
glass motorized homogenizer in 10 mmol/L Tris, pH 7.4, 250 mmol/L
sucrose, 1 mmol/L dithiothreitol, and 1 mmol/L EDTA. The total
membrane fraction was isolated by centrifugation at 100,000 3 g; 1 h.
The protein concentration was measured by the bicinchoninic acid
method (Pierce) with bovine serum albumin as the standard. GPAT
activity was assayed for 10 min at 25C with 800 mmol/L [3H]glycerol-3-
phosphate and 100 mmol/L palmitoyl-CoA in the presence or absence
of 2 mmol/L N-ethylmaleimide (NEM), which inhibits the microsomal
isoforms GPAT3 and 4 (25). The NEM-sensitive mitochondrial GPAT2
is present at very low levels in liver (26). [3H]glycerol-3-phosphate was
synthesized enzymatically (27).
Statistical analysis. Statistical analyses were performed using JMP
Statistical software (SAS Institute). Nonparametric data were analyzed
using the Kruskal Wallis test (a ¼ 0.05). Differences were considered
significant at P , 0.05. T cell response data were analyzed by 2-way
ANOVA with mouse type and effector:target ratio as main effects. A
Tukey test was used for post hoc analysis. Relationships between liver
viral titer and cytokine mRNA expression were analyzed by the non-
parametric Spearman’s rank-order correlation analysis (Spearman’s r).
Results
Following a coxsackievirus challenge, Gpat12/2 mice exhibited
increased mortality and significantly increased heart pathology.
At age 3 mo, mice were infected with CVB3. Although no wild-
type mice died, Gpat12/2 mice had an 8% mortality rate (data
not shown). In addition, cardiac pathology, characterized by
heart inflammatory infiltrate, was significantly greater in the
Gpat12/2 mice at d 10 p.i. compared with wild-type controls
(data not shown).
Increased inflammation was associated with increased
CVB3 viral load in Gpat12/2 mice. The virus titer was signi-
ficantly greater in the liver of Gpat12/2 mice at d 2 p.i (Fig. 1A)
and in the heart at d 5 p.i. (Fig. 1B) compared with wild-type
mice. Although viral titers did not differ between the groups
at d 10 p.i. (Fig. 1C), Gpat12/2 mice still had severe cardiac
inflammation compared with wild-type mice (Fig. 1).
Gpat12/2 hearts expressed increased cytokine mRNA
levels after CVB3 challenge. Cytokines help to orchestrate
immune responses both by controlling inflammatory responses
and by attracting immune cells to the site of infection. Levels of
mRNA for TNFa and iNOS (Fig. 2A) as well as IL-1b, IL-6 (Fig.
2B), and IFNa, IFNb, and IFNg (Fig. 2C) were significantly
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elevated by 1- to 2-fold in the hearts of Gpat12/2 mice at 5 d p.i.
compared with wild-type mice. Additionally, mRNA levels of
the antiinflammatory cytokine IL-10 were also significantly in-
creased (Fig. 3B). Increased cytokine mRNA levels were posi-
tively correlated with virus titer on an individual mouse basis [P #
0.05; r¼ 0.7692 (IFNb), 0.5385 (IFNg), 0.5692 (TNFa), 0.7473
(IL-6), 0.5209 (IL-10)]. Liver cytokine concentrations did not
differ between the groups at d 2 p.i. (data not shown).
Splenic NK cell activity was normal in Gpat12/2 mice. NK
cells act to eliminate virally infected cells, reducing viral spread
until adaptive mechanisms can be marshaled. Because viral titers
were higher in Gpat12/2 mice, NK cell cytotoxicity was tested
in the Gpat12/2 mice. Cytotoxicity did not differ between cells
isolated from wild-type and Gpat12/2 mice (data not shown).
The percent of NK cells (%CD32/DX51) of total cells isolated
from the spleen as determined by flow cytometry also did not
differ (data not shown).
DC from Gpat12/2 mice were able to present antigen
normally. Effective viral clearance depends on the generation of
a functional adaptive immune response. The generation of this
virus-specific response stems from the ability of DC to take up
and present antigen to T cells. DC from both groups activated
equivalent numbers of wild-type CD81 T cells to produce IFNg,
indicating that Gpat12/2 DC were able to take up and present
antigen normally (Fig. 3). In addition to the ability of DC to
present antigen, it is equally important for T cells to be able to
respond to the presented antigen. CD81 T cells from Gpat12/2
mice had lower IFNg production compared with those from
wild-type mice, indicating that GPAT1 activity is required for T
cells to properly respond to antigen presentation (Fig. 3). This
decreased T cell response in Gpat12/2 mice may have contrib-
uted to the increases in viral loads and pathology. The total
numbers and populations of T cells did not differ at any time in
the hearts of these mice (data not shown).
GPAT1 activity does not change in the liver following
CVB3 infection. Because lack of Gpat1 resulted in an altered
immune response, we measured GPAT-specific activity in the
livers of CVB3-infected mice over the course of the infection. As
expected, GPAT1-associated activity (NEM-resistant) was vir-
tually absent in the livers of Gpat12/2 mice. NEM-sensitive
GPAT activity did not change in either group during the course
of the infection (data not shown).
Discussion
Response to a viral infection requires a coordinated response of
immune cells, cytokine expression, and antigen processing and
presentation. GPAT1, a mitochondrial membrane-associated
enzyme that initiates glycerolipid synthesis, has been previously
shown to alter potential immunoregulatory factors, including T
cell function, in a noninfectious model. To determine whether
GPAT1 activity could influence the response to a viral infection,
we infected Gpat12/2 mice with CVB3. Similar to infection in
humans, CVB3 replicates in murine liver and heart tissue and
ultimately induces myocarditis in the infected host. Thus, the
resulting heart pathology is caused by inflammation associated
with the immune response directed against virus-infected
cardiomyocytes. Although the immune response contributes to
the pathology, it is also required for recovery and viral clearance.
The balance is delicate between the effectiveness of the immune
response and the potential for harmful cardiac inflammation.
Compared with wild-type C57BL/6 mice, Gpat12/2 mice had
greater mortality and cardiac pathology after CVB3 challenge.
FIGURE 1 Liver virus titers at d 2 (A) and heart virus titers at d 5 (B)
and d 10 p.i. with coxsackievirus in wild-type and Gpat12/2 mice.
Values are mean 1 SEM on a Log10 scale, n ¼ 6–8. *Different from
wild type, P , 0.05.
FIGURE 2 Heart mRNA levels for murine
cytokines, chemokines, and G3PDH at d 5
p.i. mRNA levels of TNFa, iNOS (A), IL-6, -10,
and -1b (B), as well as IFNa, -b, and -g (C)
were tested. Values are mean 6 SEM by
normalization to G3PDHs, n ¼ 6–8. *Differ-
ent from wild type, P , 0.05.
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On d 5 p.i., viral titers and cytokine mRNA levels were greater in
the hearts of the Gpat12/2 mice. These data suggest that the
infectivity and virulence of coxsackievirus is influenced by the
absence of GPAT1 activity. The increased viral titers likely
induced the increased inflammatory response; however, the
reason for the increased viral titers in the Gpat12/2 mice
remains unclear. Loss of GPAT1 may alter the liver microenvi-
ronment and allow greater replication or spread of CVB3. For
example, liver oxidative stress is increased in Gpat12/2 mice (6).
Earlier work in our laboratory and others has demonstrated
increased CVB3 viral replication under conditions of increasing
oxidative stress (28–30). Similarly, heart tissue from Gpat12/2
mice may also exhibit increased oxidative stress, leading to
increased viral replication.
To combat viral infection, macrophages, neutrophils, and DC
are recruited to the infected area where they secrete proin-
flammatory cytokines. These mediators then act both to reduce
viral replication and to attract and activate adaptive immune
cells capable of clearing the remaining viral infection (31). The
acute myocarditis that occurs in the heart around d 5 p.i. is
comprised of inflammatory infiltrates of macrophages, neutro-
phils, DC, NK cells, and CD81 T cells (19,32). Altered
functionality of these cells could result in the increased pathol-
ogy in the Gpat12/2 mice. DC isolated from both Gpat12/2 and
wild-type mice were able to induce similar numbers of CD81 T
cells to secrete IFNg. Additionally, NK cell cytotoxicity was
not reduced in Gpat12/2 mice. Thus, GPAT1 activity is not
necessary for DC or NK function and, taken together, these
results suggest that these cells of the innate immune response are
not directly affected by a lack of GPAT1 activity. However, an
early increase in viral titers at a time during which viral
replication is controlled by the innate immune response as well
as an increase in innate proinflammatory cytokines suggests that
GPAT1 does influence the innate immune response.
Because DC from Gpat12/2 mice presented antigen normally,
we testedwhether Gpat12/2 T cells were able to respond to antigen
presentation. The finding of elevated viral titers and enhanced heart
inflammation in the Gpat12/2 mice suggested that T cells were not
adequately regulating the viral infection. T lymphocytes play a
varied role in coxsackievirus B3-induced myocarditis (33). The
severity of myocardial damage and the associated mortality depend
on the predominant T cell type that is available to respond to CVB3
infection (20,34). The response of T cells from Gpat12/2 mice was
greatly reduced when presented with antigen displayed on wild-
type DC. Thus, T cell function was impaired in these mice. These
results indicate that viral clearance by T cells is inadequate in
Gpat12/2 mice and may contribute to the increased myocarditis. In
previous studies, knockout of CD81 T cells resulted in greater
disease severity comparedwitha knockout of CD41 cells; however,
both types of knockout mice displayed greater mortality than wild-
type controls (35). The exact mechanism by which GPAT1 activity
affects T cells is unknown. Because lipid 2nd messengers such as
phospholipids and diacylglycerol are extremely important in T cell
activation (36–38), future studies will focus on the contribution of
GPAT1 to the generation of these lipid 2nd messengers as well as the
effects of these lipids on T cell-specific activation proteins such as
protein kinase C u, phospholipase C, and diacylglycerol kinase.
Taken together, these data obtained from Gpat12/2 mice
indicate that the adaptive arm of the immune response requires
GPAT1 activity. Increased viral infectivity and replication as well
as reduced viral clearance results in increased pathology and
increased mortality in the Gpat12/2 mice. Thus, glycerolipid
synthesis may play a more important role in the immune response
than previously suspected.
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